Breaking News Instant updates and real-time market news.

DIS

Disney

$152.41

2.79 (1.86%)

, MCD

McDonald's

$192.55

0.62 (0.32%)

10:09
11/26/19
11/26
10:09
11/26/19
10:09

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Disney (DIS) initiated with an Overweight at Consumer Edge. 2. McDonald's (MCD) initiated with a Hold at Deutsche Bank. 3. IMV Inc. (IMV) initiated with an Outperform at Oppenheimer. 4. Fortress Transportation (FTAI) initiated with a Buy at B. Riley FBR. 5. Marathon Oil (MRO) initiated with a Neutral at Guggenheim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

DIS

Disney

$152.41

2.79 (1.86%)

MCD

McDonald's

$192.55

0.62 (0.32%)

IMV

IMV Inc.

$2.26

0.03 (1.35%)

FTAI

Fortress Transportation

$17.43

0.47 (2.77%)

MRO

Marathon Oil

$12.07

-0.05 (-0.41%)

DIS Disney
$152.41

2.79 (1.86%)

11/25/19
CEDG
11/25/19
INITIATION
Target $175
CEDG
Overweight
Disney initiated with an Overweight at Consumer Edge
Consumer Edge Research initiated coverage of Disney with an Overweight rating and $175 price target.
11/20/19
IMPC
11/20/19
NO CHANGE
Target $143
IMPC
In-Line
Imperial Capital ups Disney target to $143 ahead of Frozen 2 debut
Imperial Capital analyst David Miller raised his price target for Disney to $143 from $141 with Frozen 2 set to debt on roughly 6,950 screens. This should "materially improve" the U.S. box office pacing number, Miller tells investors in a research note. The analyst keeps an In-Line rating on Disney shares.
11/19/19
RSBL
11/19/19
NO CHANGE
Target $175
RSBL
Rosenblatt boosts Disney target to $175 after second streaming survey
Following his second streaming video survey over the weekend, Rosenblatt analyst Bernie McTernan raised his price target for Disney to $175 from $170 and reiterated the shares as his top pick in Media. The analyst now assumes 21M global Disney+ subscribers at the end of December and 35M at the end of fiscal 2020. The analyst says awareness of Disney+ increased dramatically from his last survey. 84% of respondents indicated they were aware of Disney's streaming service, up from 63% in his prior survey published on October 27. McTernan believes Disney+ current has 15M-20M subscribers. He reiterates a Buy rating on Disney shares.
11/22/19
PIPR
11/22/19
NO CHANGE
Target $400
PIPR
Overweight
Piper survey finds one third of U.S. Netflix subscribers want Disney+
Disney's (DIS) streaming service has now been out for ten days and current Netflix (NFLX) subscribers appear to have a fairly strong interest in the service, Piper Jaffray analyst Michael Olson tells investors in a research note. The analyst surveyed 1,700 domestic Netflix subscribers to gauge interest in Disney+ and found that 33% expect to subscribe to Disney+, up from 28% in September and 27% in April. Increasing awareness of the service is driving rising subscriber interest, says the analyst. However, Olson points out that despite rising interest in Disney+, he has seen a "consistent indication" that only a mid-single digit percentage of Netflix subscribers expect to cancel in favor of Disney+. Further, at any given time, there is a single digit percentage of Netflix subscribers that expect to cancel the service in the next few months, adds the analyst. Olson still expects Netflix will continue to capture a significant portion of traditional content dollars as they migrate to streaming. He maintains an Overweight rating on the shares with a $400 price target. The stock closed Thursday up $6.53 to $311.69.
MCD McDonald's
$192.55

0.62 (0.32%)

11/25/19
LBOW
11/25/19
NO CHANGE
LBOW
Buy
McDonald's U.S. comp growth stabilized in quarter-to-date, says Longbow
Longbow analyst Alton Stump said his checks with U.S. McDonald's franchisees lead him to believe that same-store sales are up 4.5%-5% to date in Q4, which he thinks would be viewed positively by most investors since it would represent a stabilization sequentially compared to the sequential deceleration in comps reported in Q3. The return of McDonald's buy-one-get-one for $1 deal has performed well again since its return, franchisees told Stump, who keeps a Buy rating on the stock.
11/19/19
CLVD
11/19/19
NO CHANGE
CLVD
McDonald's U.S. comps appear slow to start November, says Cleveland Research
Cleveland Research said its checks indicate that U.S. comps for McDonald's look to have slowed so far in November due to weather and "underwhelming" promotions. The firm lowered its Q4 US comp growth forecast to 4.5%, which compares to a 4.7% consensus forecast.
11/26/19
DBAB
11/26/19
INITIATION
Target $193
DBAB
Hold
McDonald's initiated with a Hold at Deutsche Bank
Deutsche Bank initiated coverage of McDonald's with a Hold rating and $193 price target.
11/08/19
11/08/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McDonald's (MCD) upgraded to Buy from Neutral at Longbow with analyst Alton Stump saying though disappointed by Steve Easterbrook's departure, Chris Kempczinski has played an integral role alongside Easterbrook in driving the company's "impressive" domestic same-store sales recovery and he believes McDonald's "is in good hands" under its new CEO. 2. Foot Locker (FL) upgraded to Positive from Neutral at Susquehanna with analyst Sam Poser saying he believes its outlook for Q3 and Q4 will be better than anticipated. 3. WWE (WWE) upgraded to Buy from Neutral at Citi with analyst Jason Bazinet saying the stock's risk/reward is "now compelling." 4. Qualcomm (QCOM) upgraded to Hold from Sell at DZ Bank. 5. Cummins (CMI) upgraded to Outperform from In Line at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
IMV IMV Inc.
$2.26

0.03 (1.35%)

10/28/19
10/28/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Roku (ROKU) initiated with a Buy at BofA/Merrill. 2. IMV Inc. (IMV) initiated with a Market Perform at Wells Fargo. 3. Yum China (YUMC) initiated with a Buy at Jefferies. 4. Purple (PRPL) initiated with a Buy at Roth Capital. 5. Robert Half (RHI) initiated with a Buy at CL King. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/28/19
WELS
10/28/19
INITIATION
Target $3
WELS
Market Perform
IMV Inc. initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Jim Birchenough initiated coverage of IMV Inc. with a Market Perform rating and $3 price target. The company has a "promising" cancer vaccine, but initial results for lead cancer vaccine DPX-Survivac in ovarian cancer has been mixed, Birchenough tells investors in a research note. The analyst is taking a "wait-and-see approach" to broader patient exposure and longer duration of follow-up.
11/25/19
OPCO
11/25/19
INITIATION
Target $9
OPCO
Outperform
IMV Inc. initiated with an Outperform at Oppenheimer
Oppenheimer analyst Jay Olson initiated coverage of IMV Inc. with an Outperform rating and C$9 price target.
11/26/19
OPCO
11/26/19
INITIATION
Target $9
OPCO
Outperform
IMV initiated with an Outperform and C$9 target at Oppenheimer
Oppenheimer analyst Jay Olson last night initiated coverage of IMV Inc. with an Outperform rating and C$9 price target. The analyst believes IMV's approach of combining precision oncology with immunotherapy is unique, while pursuing new previously undrugged Survivin targets could lead to "major breakthroughs" in oncology. He cites the company's potential in two indications for DPX-Survivac, ovarian cancer and diffuse large B-cell lymphoma, for his Outperform rating.
FTAI Fortress Transportation
$17.43

0.47 (2.77%)

11/26/19
STFL
11/26/19
INITIATION
Target $22
STFL
Buy
Fortress Transportation initiated with a Buy at Stifel
Stifel analyst Benjamin Nolan initiated coverage of Fortress Transportation with a Buy rating and $22 price target. Catalysts such as positive infrastructure EBITDA, monetizing upside in aviation assets, aviation advanced repair program, Jefferson pipeline and storage build-out should drive shares higher in the next several quarters, Nolan tells investors in a research note. The analyst believes the market is not representing the company's true opportunity in the share price.
11/26/19
RILY
11/26/19
INITIATION
Target $23
RILY
Buy
Fortress Transportation initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Scott Buck initiated coverage of Fortress Transportation & Infrastructure with a Buy rating and $23 price target.
11/26/19
RILY
11/26/19
INITIATION
Target $23
RILY
Buy
B. Riley FBR sees 'multiple opportunities' for Fortress Transport shares
B. Riley FBR analyst Scott Buck initiated coverage of Fortress Transportation & Infrastructure with a Buy rating and $23 price target. The analyst sees "multiple opportunities" for share appreciation, as he expect the company's monetization of some infrastructure assets to be used to invest in additional high-return aviation assets and pay down debt. Further, Fortress' potential shift away from the K-1 tax structure will likely increase the number of institutional investors willing to own the shares, Buck tells investors in a research note.
MRO Marathon Oil
$12.07

-0.05 (-0.41%)

09/23/19
SBSH
09/23/19
INITIATION
Target $13
SBSH
Neutral
Marathon Oil initiated with a Neutral, $13 price target at Citi
Citi analyst Scott Gruber started Marathon Oil with a Neutral rating and $13 price target. The company's inventory lags the group and thus it's long term production profile is at the low end of the group range, Gruber tells investors in a research note.
09/24/19
TUDR
09/24/19
DOWNGRADE
Target $16
TUDR
Hold
Marathon Oil downgraded to Hold from Buy at Tudor Pickering
Tudor Pickering analyst Matthew Portillo downgraded Marathon Oil to Hold from Buy and lowered his price target on the shares to $16 from $18.
09/24/19
09/24/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Altra Industrial Motion (AIMC) downgraded to Sector Weight from Overweight at KeyBanc with analyst Jeffrey Hammond saying around $400M of Altra's revenue, or 20% of total sales, derives from Class 8 Truck and Industrial-Germany, markets which could decline 15% year-over-year in 2020. 2. Brinker (EAT) downgraded to Neutral from Overweight at JPMorgan with analyst John Ivankoe saying he recommends taking short-term profits in the shares. 3. Marathon Oil (MRO) downgraded to Hold from Buy at Tudor Pickering. 4. Park Hotels & Resorts (PK) downgraded to an Underweight from Neutral at JPMorgan with analyst Brandt Montour saying he views the lodging real estate investment trust as relatively unattractive compared to the lodging C-corps. 5. Blackstone (BX) downgraded to Perform from Outperform at Oppenheimer with analyst Chris Kotowski saying the stock is up 79% year to date versus up 18% year to date for the S&P 500 and reached his price objective. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/26/19
GUGG
11/26/19
INITIATION
GUGG
Neutral
Marathon Oil initiated with a Neutral at Guggenheim
Guggenheim analyst Subash Chandra initiated coverage of Marathon Oil with a Neutral rating.

TODAY'S FREE FLY STORIES

ITCI

Intra-Cellular

$11.05

0.85 (8.33%)

10:55
12/09/19
12/09
10:55
12/09/19
10:55
Options
Intra Cellular Therapies put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Dec

CP

Canadian Pacific

$243.62

-1.86 (-0.76%)

10:52
12/09/19
12/09
10:52
12/09/19
10:52
Periodicals
Canadian Pacific crude train catches fire after derailing, Reuters reports »

A Canadian Pacific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

$109.98

3.3 (3.09%)

, SWKS

Skyworks

$103.99

2.59 (2.55%)

10:50
12/09/19
12/09
10:50
12/09/19
10:50
On The Fly
Qorvo, Skyworks jump as BofA expresses optimism about 5G prospects »

Shares or Qorvo (QRVO)…

QRVO

Qorvo

$109.98

3.3 (3.09%)

SWKS

Skyworks

$103.99

2.59 (2.55%)

AAPL

Apple

$269.73

-0.95 (-0.35%)

MRVL

Marvell

$23.75

-0.43 (-1.78%)

ADI

Analog Devices

$114.78

-1.17 (-1.01%)

XLNX

Xilinx

$91.80

-0.07 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Jan

  • 28

    Jan

AMZN

Amazon.com

$1,759.42

8.63 (0.49%)

, MSFT

Microsoft

$151.80

0.03 (0.02%)

10:46
12/09/19
12/09
10:46
12/09/19
10:46
Periodicals
Amazon says Trump exerted 'improper pressure' in Pentagon contract, WSJ reports »

Amazon (AMZN) is claiming…

AMZN

Amazon.com

$1,759.42

8.63 (0.49%)

MSFT

Microsoft

$151.80

0.03 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CGC

Canopy Growth

$20.83

2.18 (11.69%)

10:45
12/09/19
12/09
10:45
12/09/19
10:45
Options
Canopy Growth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
12/09/19
12/09
10:45
12/09/19
10:45
General news
FX Action: USD-JPY »

FX Action: USD-JPY was…

NOK

Nokia

$3.44

-0.04 (-1.15%)

, DDAIF

Daimler AG

$0.00

(0.00%)

10:44
12/09/19
12/09
10:44
12/09/19
10:44
Periodicals
Nokia pauses legal action against Daimler with mediation offer, Reuters reports »

Nokia (NOK) has…

NOK

Nokia

$3.44

-0.04 (-1.15%)

DDAIF

Daimler AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPPI

Spectrum

$9.83

(0.00%)

10:35
12/09/19
12/09
10:35
12/09/19
10:35
Options
Spectrum put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTIC

CTI BioPharma

$0.95

(0.00%)

10:33
12/09/19
12/09
10:33
12/09/19
10:33
Hot Stocks
CTI BioPharma: PAC203 results show pactritinib 200mg 'well tolerated' »

CTI BioPharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
12/09/19
12/09
10:25
12/09/19
10:25
General news
Concerns over a year-end spike in the money markets »

Concerns over a year-end…

10:25
12/09/19
12/09
10:25
12/09/19
10:25
Conference/Events
JPMorgan Mexican strategist to hold an analyst/industry conference call »

Mexican Equity Strategist…

10:25
12/09/19
12/09
10:25
12/09/19
10:25
Conference/Events
UBS alternative energy windham to hold an analyst/industry conference call »

Alternative Energy &…

ZG

Zillow

$40.54

-0.18 (-0.44%)

, SPCE

Virgin Galactic

$8.20

0.92 (12.64%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

ZG

Zillow

$40.54

-0.18 (-0.44%)

SPCE

Virgin Galactic

$8.20

0.92 (12.64%)

PAA

Plains All American

$17.29

-0.01 (-0.06%)

PAGP

Plains GP Holdings

$17.37

0.01 (0.06%)

SSKN

Strata Skin Sciences

$2.20

0.04 (1.85%)

ZYME

Zymeworks

$41.25

-0.45 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 30

    Dec

  • 04

    Feb

MMM

3M

$169.82

-1.675 (-0.98%)

, PNC

PNC Financial

$153.68

-0.13 (-0.08%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

MMM

3M

$169.82

-1.675 (-0.98%)

PNC

PNC Financial

$153.68

-0.13 (-0.08%)

M

Macy's

$14.96

-0.19 (-1.25%)

CVX

Chevron

$117.18

-0.8 (-0.68%)

HBIO

Harvard Bioscience

$2.83

-0.12 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 15

    Jan

QRVO

Qorvo

$109.72

3.04 (2.85%)

, SWKS

Skyworks

$104.55

3.15 (3.11%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

QRVO

Qorvo

$109.72

3.04 (2.85%)

SWKS

Skyworks

$104.55

3.15 (3.11%)

FATE

Fate Therapeutics

$19.69

6.05 (44.35%)

WING

Wingstop

$84.26

4.04 (5.04%)

HUN

Huntsman

$23.31

0.48 (2.10%)

FTV

Fortive

$74.68

1.82 (2.50%)

DOW

Dow Inc.

$53.29

0.04 (0.08%)

KRA

Kraton

$23.96

0.92 (3.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

  • 13

    Dec

  • 18

    Dec

  • 19

    Dec

TPR

Tapestry

$25.85

0.305 (1.19%)

10:20
12/09/19
12/09
10:20
12/09/19
10:20
Options
Upside February calls see heavy trading in Tapestry »

Upside February calls see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWTX

SpringsWorks Therapeutics

$28.00

3.01 (12.04%)

, GSK

GlaxoSmithKline

$45.64

0.13 (0.29%)

10:19
12/09/19
12/09
10:19
12/09/19
10:19
Hot Stocks
SpringsWorks reports Glaxo presentation of preclinical data on nirogacestat »

SpringWorks Therapeutics…

SWTX

SpringsWorks Therapeutics

$28.00

3.01 (12.04%)

GSK

GlaxoSmithKline

$45.64

0.13 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/09/19
12/09
10:17
12/09/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGIO

Agios Pharmaceuticals

$44.49

3.56 (8.70%)

10:16
12/09/19
12/09
10:16
12/09/19
10:16
Hot Stocks
Agios Pharmaceuticals reports new data from DRIVE PK Phase 2 study »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 13

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/09/19
12/09
10:16
12/09/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSV

Forty Seven

$22.25

7.85 (54.51%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Hot Stocks
Forty Seven announces preclinical proof-of-concept data for FSI-174 »

Forty Seven announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

NKTR

Nektar

$22.00

1.55 (7.58%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Hot Stocks
Nektar announces presentation of data for NKTR-255 at ASH »

Nektar Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

UPS

UPS

$116.87

-0.67 (-0.57%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Hot Stocks
UPS reports expansion of UPS Worldwide Express, Express Plus across 40 countries »

UPS announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$60.30

-0.69 (-1.13%)

10:15
12/09/19
12/09
10:15
12/09/19
10:15
Options
Centene put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

CNST

Constellation Pharmaceuticals

$47.50

3.4 (7.71%)

10:14
12/09/19
12/09
10:14
12/09/19
10:14
Hot Stocks
Breaking Hot Stocks news story on Constellation Pharmaceuticals »

Constellation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.